Experts at the European Medicines Agency are preparing to present the conclusions of their investigation later on Tuesday into possible links between the J&J coronavirus vaccine and very rare cases of unusual clotting disorders detected in the US. Last week, J&J halted the European rollout of its one-dose vaccine after the USFDA recommended officials pause its use while the rare blood clot cases are examined.
No comments:
Post a Comment